| Literature DB >> 27625703 |
Jelena Filipović1, Gordana Joksić1, Dragana Vujić2, Ivana Joksić1, Kristin Mrasek3, Anja Weise3, Thomas Liehr3.
Abstract
BACKGROUND: Fanconi anemia (FA) is a chromosomal instability syndrome characterized by increased frequency of chromosomal breakages, chromosomal radial figures and accelerated telomere shortening. In this work we performed detailed molecular-cytogenetic characterization of breakpoints in primary lymphocytes of FA-D2 patients in different stages of the disease using fluorescent in situ hybridization.Entities:
Keywords: Fanconi anemia; Fragile sites; Radial figures; Telomere fusions; X chromosome
Year: 2016 PMID: 27625703 PMCID: PMC5020439 DOI: 10.1186/s13039-016-0280-6
Source DB: PubMed Journal: Mol Cytogenet ISSN: 1755-8166 Impact factor: 2.009
BAC-probes used for fluorescence in situ hybridization for the most breakpoint-affected chromosomal regions
| Chromosomal region | Fragile site (FS) | FS typea | BAC-probe | Co-localization of FA breakpoints and FS |
|---|---|---|---|---|
| 1p13.3 | FRA1N | Aphidicolinb | RP11-242D10 | + |
| 1q21.2 | FRA1F | Aphidicolin | RP11-301 M17 | + |
| 1q42.2 | Near FRA1H | Azacytidin | RP11-109G24 | − |
| 2q35 | FRA2U | Aphidicolin | RP11-316O14 | + |
| 3p14.2 | FRA3B | Aphidicolin | RP11-129 K20 | + |
| 3p21.31 | FRA3H | New nomenclaturec | RP11-787O14 | + |
| 3q27.1 | FRA3C | Aphidicolin | RP11-110C15 | + |
| 5q13.2 | FRA5K | New nomenclatured | RP11-497H16 | + |
| 5q33.2 | FRA5O | New nomenclatured | RP11-265I24 | + |
| 7q22.3 | FRA7F | Aphidicolin | CTB-20D2 | + |
| 7q32.3 | FRA7H | Aphidicolin | RP11-138A9 | + |
| 11q13 | FRA11H | Aphidicolin | RP11-449G14 | + |
| 14q24.3 | FRA14G | Aphidicolinb | RP3-414A15 | + |
| 16q22.1 | FRA16C, FRA16B | Aphidicolin | RP11-106 J23 | + |
| 16q23 | FRA16D | Aphidicolin | RP11-358 L22 | + |
| 18q21.3 | FRA18B | Aphidicolin | RP11-15C15 | + |
BAC-probes for the appropriate FSs were selected according to the literature data:
aNomenclature according to Lukusa et al. [33]
bNew extended nomenclature according to Mrasek et al. [34]
cCommon according to the nomenclature by Borgaonkar [35]
dCommon according to the nomenclature by Simonic and Gericke [36]
FA-D2 patients’ karyotypes and molecular cytogenetic findings
| FA-D2 patient | Age (years) | Karyotype | Most frequent breakpoints | Fragile site (FS) | Breakpoint frequency (%) | Telomere fusion frequency (%) | Average telomere length (RTLUa ± SD) | Radial figures frequency (%) | |
|---|---|---|---|---|---|---|---|---|---|
| Group A | 1 | 8 | 46,XX | 1q42.2 | distal to FRA1H | 1.72 | 1.95 | 14.76 ± 3.23 | 7.06 |
| 14q24.3 | FRA14G | 3.09 | |||||||
| 18q21.3 | FRA18B | 1.72 | |||||||
| 2 | 6 | 46,XX | 2q35 | FRA2U | 2.4 | 1.54 | 23.02 ± 12.73 | 1.78 | |
| 3p14.2 | FRA3B | 2.4 | |||||||
| 5q33.2 | FRA5O | 2 | |||||||
| 7q32.3 | FRA7H | 1.6 | |||||||
| 3 | 17 | 46,XX | 3q27.1 | FRA3C | 2.75 | 1.62 | 35.72 ± 7.00 | 1.88 | |
| 5q13.2 | FRA5K | 2.75 | |||||||
| 5q33.2 | FRA5O | 3.29 | |||||||
| Group B | 4 | 3 | 46,XX | 3p14.2 | FRA3B | 11.07 | 0.08 | 20.48 ± 12.24 | 0.78 |
| 3p21.31 | FRA3H | 3.95 | |||||||
| 7q32.3 | FRA7H | 1.19 | |||||||
| 5 | 3 | 46,XX,der(21)t(15;21)(q15;p11.1)[5]/46,XX [15] | 1p13 | FRA1N | 1.76 | 0.72 | 21.01 ± 10.33 | 0.715 | |
| 1q21 | FRA1F | 1.32 | |||||||
| 3p21.31 | FRA3H | 1.32 | |||||||
| 11q13 | FRA11H | 0.88 | |||||||
| 6 | 11 | 46, XY, der(16)t(1;16)(q42;p11.2)del(1) (q42)[1]/46,XY[31] | 3p14.2 | FRA3B | 1.88 | 0.23 | 23.91 ± 6.92 | 0.23 | |
| 3p21.31 | FRA3H | 0.63 | |||||||
| 16q22.1 | FRA16C | 1.88 | |||||||
| 16q23 | FRA16D | 6.88 |
aRTLU–relative telomere length units
Fig. 1Representative images of BAC-FISH in FA-D2 metaphases, inverted DAPI and DAPI staining. Arrows indicate breakpoints and hybridized BAC-probes; RP11-265I24 located within FRA5O (a), and RP11-109G24 located within 1q42.2, near FRA1H (b)
Fig. 2Percentage of telomere fusions in group A and B patients. Group A display more fusions than group B
Fig. 3Percentage of radial figures in group A and B patients. In Group A incidence of radials was six fold higher compared to group B
Fig. 6Representative images of telomere FISH in FA-D2 metaphases. Telomere signals at the fusion points are indicated by green arrow: telomere end-to-end fusion, three signals are present between two chromosomes (a), radial figure between chromosomes X and 13, red arrow indicates X chromosome in radial figure (b), green arrow indicates radial figure between telomere of one and interstitial region of another chromosome (c), blue arrow indicates simple radial figure (d). Scale bars = 10 μm
Fig. 4Chromosomes involved in telomere fusions in group A and B
Fig. 5Chromosomes involved in radial figures in both patient groups
Genes located within common fragile sites according to the literature dataa, b, c, d
| Fragile site | Chromosomal region | Start | End | Gene | Gene length |
|---|---|---|---|---|---|
| Molecularly characterized fragile sites | |||||
| FRA3B | 3p14.2 | 58 600 001 | 63 800 000 | FHITa | >1.5 Mbp |
| FRA7H | 7q32.3 | 130 800 001 | 132 900 000 | /b | / |
| FRA16D | 16q23.2 | 79 200 001 | 81 600 000 | WWOXc | 1.1 Mbp |
| Not-characterized fragile sitesd | |||||
| FRA1F | 1q21.2 | 147 500 001 | 150 600 000 | 33 genes | / |
| FRA1N | 1p13.3 | 106 700 001 | 111 200 000 | 52 genes | / |
| FRA2U | 2q35 | 214 500 001 | 220 700 000 | 70 genes | / |
| FRA3C | 3q27.1 | 183 000 001 | 184 800 000 | 20 genes | / |
| FRA3H | 3p21.31 | 44 200 001 | 50 600 000 | 78 genes | / |
| FRA5K | 5q13.2 | 69 100 001 | 74 000 000 | 25 genes | / |
| FRA5O | 5q33.2 | 153 300 001 | 156 300 000 | 8 genes | / |
| FRA7F | 7q22.3 | 104 900 001 | 107 800 000 | 14 genes | / |
| FRA11H | 11q13.4 | 70 500 001 | 75 500 000 | 48 genes | / |
| FRA14G | 14q24.3 | 73 300 001 | 78 800 000 | 69 genes | / |
| FRA16C | 16q22.1 | 66 600 001 | 70 800 000 | 95 genes | / |
| FRA18B | 18q21.3 | 61 300 001 | 63 900 000 | 10 genes | / |
aAccording to Zimonjic et al. [37]
bAccording to Mishmar et al. [38]
cAccording to Ried et al. [39]
dAccording to National Center for Biotechnology Information [40]